Organon & Co | OGN - Pre Tax Profit


Organon & Co reported $-148M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Celltrion KRW 10.5B 4.1B Dec/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 9.63B 1.09B Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Merck USD 3.42B 3.32B Dec/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Novartis USD 5.17B 637M Sep/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Organon & Co USD -148M 391M Dec/2025
Pharma Mar EUR 1.6M 38.6M Mar/2026
Qiagen NV USD 109.17M 25.56M Dec/2025
Sartorius EUR 157.8M 76.1M Mar/2026
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025